Sleeping pills linked to a higher death risk

Sleeping pills appear to be linked with a higher death risk, US doctors warn.

The US study, published in BMJ Open, compared more than 10,000 patients on tablets like temazepam with 23,000 similar patients not taking these drugs.

Death risk among users was about four times higher, although the absolute risk was still relatively low.

Experts say while the findings highlight a potential risk, proof of harm is still lacking.

Researchers say patients should not be alarmed nor stop their medication, but if they are concerned they should discuss this with their doctor or pharmacist.

The latest study looked at a wide range of sleeping pills, such as benzodiazepines (temazepam and diazepam), non-benzodiazepines (zolpidem, zopiclone and zaleplon), barbiturates and sedative antihistamines.

Sleeping pills appear to be linked with a higher death risk, US doctors warn

The investigators, from the Jackson Hole Centre for Preventive Medicine in Wyoming and the Scripps Clinic Viterbi Family Sleep Centre in California, found that people prescribed these pills were 4.6 times more likely to die during a 2.5-year period compared to those not on the drugs.

Overall, one in every 16 patients in the sleeping pill group died (638 out of 10,531 in total) compared to one in every 80 of the non-users (295 deaths out of 23,674 patients).

This increased risk was irrespective of other underlying health conditions, such as heart and lung diseases, and other factors like smoking and alcohol use, which the researchers say they did their best to rule out.

The researchers say it is not yet clear why people taking sleeping tablets may be at greater risk.

The drugs are sedating and this may make users more prone to falls and other accidents. The tablets can also alter a person’s breathing pattern as they sleep and they have been linked to increased suicide risk.

In this latest study, those taking the highest doses of sleeping tablets also appeared to be at greater risk of developing cancer.

The researchers say: “The meagre benefits of hypnotics, as critically reviewed by groups without financial interest, would not justify substantial risks.”

They say even short-term use may not be justifiable.

 

Kathryn R. Bown

Kathryn - Our health specialist likes to share with the readers the latest news from the field. Nobody understands better than her the relation between healthy mind and healthy body.

Recent Posts

House Panel Votes to Release Matt Gaetz Ethics Report

The US House Ethics Committee has voted to release its report on former Republican Representative…

4 days ago

ABC News to Pay $15M to Settle Trump Defamation Suit

ABC News has agreed to pay $15 million to President-elect Donald Trump to settle a…

1 week ago

South Korea’s Parliament Impeaches President Yoon Suk Yeol Following Martial Law Scandal

South Korea’s parliament has voted to impeach President Yoon Suk Yeol over his failed attempt…

1 week ago

Syria: Israeli War Planes Carry Out More Than 100 Air Strikes

Israeli war planes have carried out more than 100 air strikes in Syria on December…

2 weeks ago

Donald Trump Threatens 100% Tariff on BRICS Nations

President-elect Donald Trump has threatened to impose 100% tariffs on the BRICS countries if they…

3 weeks ago

Syria Coup: Rebels Take Control of Aleppo

Syrian troops have withdrawn from the city of Aleppo following an offensive by rebels opposed…

3 weeks ago